Tapimmune Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Tapimmune Inc
TickerMRKR
CIK #0001094038
CUSIP57055L206
SectorLife Sciences - Pharmaceutical Preparations
AddressUnit 2 - 3590 West 41St Avenue, Vancouver, BC V6N 3E6
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Marker Therapeutics Inc 2024-12-30 16.1 M Exemption: 506(b) · Minimum: $100,000 · Duration: One year or less · Commission: $816,000 · Revenue: Decline to Disclose
Tapimmune Inc 2018-05-24 3.1 M Exemption: 506(b) · Duration: One year or less · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001094038] 10-K
[0001094038] 10-Q
[0001094038] 3
[0001094038] 4
[0001094038] 5
[0001094038] 8-K
[0001094038] D
[0001094038] SC 13D
[0001094038] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Blue Owl Capital Holdings LP Marker Therapeutics Inc [2025-02-14] 0.0
Alyeska Investment Group LP Marker Therapeutics Inc [2025-02-14] 0.0
Wilson John Robert Marker Therapeutics Inc [2019-02-14] 17.37
Perceptive Advisors LLC Marker Therapeutics Inc [2019-02-14] 7.5
Vera Juan Marker Therapeutics Inc [2019-02-14] 5.9
LEEN Ann M Marker Therapeutics Inc [2019-02-14] 5.9
New Enterprise Associates 16 LP Marker Therapeutics Inc [2018-10-25] 17.8
Aisling Capital IV LP Marker Therapeutics Inc [2018-10-19] 7.7
Iroquois Capital Management LLC Tapimmune Inc [2018-04-04] 5.5
Eastern Capital Ltd Tapimmune Inc [2017-08-25] 33.8
Eastern Capital Ltd Tapimmune Inc [2015-03-17] 52.0
American Capital Management LLC Tapimmune Inc [2015-03-16] 7.72
Iroquois Capital Management LLC Tapimmune Inc [2015-03-13] 0.9
BRIO Capital Master Fund Ltd Tapimmune Inc [2015-01-12] 9.99
Empery Asset Management LP Tapimmune Inc [2015-01-12] 5.2
Empery Asset Management LP Tapimmune Inc [2014-08-25] 8.22
Centra Holdings Inc Tapimmune Inc [2013-09-24] 0.9
Tonaquint Inc Tapimmune Inc [2013-04-12] 0.9
[2013-02-27] None
[2013-01-07] None
Form 3/4/5 Filer 2011 - 2026
Knobil Katharine
Tapimmune Inc
Eansor Norman David
Elms Steve
Corzo Kathryn Penkus
Vera Juan
NEA Partners 16 LP
Baskett Forest
Behbahani Ali
Chang Carmen
Walker Paul Edward
Sandell Scott D
New Enterprise Associates 16 LP
Florence Anthony A Jr
Makhzoumi Mohamad
NEA 16 GP LLC
Lurier Eliot M
Wilson John Robert
Koneru Mythili
Hoang Tsvetelina P
Loiacono Michael
Szymanska Anna
Agopyan Nadia
Laskow-Pooley David
Hoang Peter L
Kim Anthony H
Garrett Gerald
Wasserman Frederick Gerald
Sonsini Peter W
Makower Joshua
Leen Ann M
Portfolio Services Ltd
Eastern Capital LTD
Dart Kenneth Bryan
Moseley Ken
Mott David M
Viswanathan Ravi
Barris Peter J
Silverman Joshua
Grisewood Sherry
Reddish Mark
Wilson Glynn
Bonfiglio John N
Corin Denis
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Knobil Katharine
Stock Option (Right to Buy) · derivative
2025-11-17 Grant 137,330 $0.00
Knobil Katharine
Stock Option (Right to Buy) · derivative
2025-11-17 Grant 84,411 $0.00
Eansor Norman David
Stock Option (Right to Buy) · derivative
2025-11-17 Grant 84,411 $0.00
Eansor Norman David
Stock Option (Right to Buy) · derivative
2025-11-17 Grant 137,330 $0.00
Elms Steve
Stock Option (right to buy) · derivative
2025-11-17 Grant 84,411 $0.00
Elms Steve
Stock Option (right to buy) · derivative
2025-11-17 Grant 137,330 $0.00
Corzo Kathryn Penkus
Stock Option (Right to Buy) · derivative
2025-10-31 Grant 147,611 $0.00
Vera Juan
Employee Stock Option (right to buy) · derivative
2025-10-31 Grant 250,000 $0.00
Elms Steve
Stock Option (right to buy) · derivative
2025-02-12 Grant 30,000 $0.00
Knobil Katharine
Stock Option (right to buy) · derivative
2025-02-12 Grant 30,000 $0.00
Eansor Norman David
Stock Option (right to buy) · derivative
2025-02-12 Grant 30,000 $0.00
Vera Juan
Employee Stock Option (right to buy) · derivative
2025-02-12 Grant 50,000 $0.00
Elms Steve
Common Stock
2024-12-23 Buy 11,085 $3.20 35,472
NEA Partners 16 LP +9
Common Stock
2024-12-23 Buy 554,250 $3.20 1,773,600
Eansor Norman David
Stock Option (right to buy) · derivative
2023-06-06 Grant 8,000 $0.00
Wilson John Robert
Stock Option (right to buy) · derivative
2023-06-06 Grant 8,000 $0.00
Elms Steve
Stock Option (right to buy) · derivative
2023-06-06 Grant 8,000 $0.00
Knobil Katharine
Stock Option (right to buy) · derivative
2023-06-06 Grant 8,000 $0.00
Vera Juan
Employee Stock Option (right to buy) · derivative
2023-05-10 Grant 100,000 $0.00
Koneru Mythili
Employee Stock Option (right to buy) · derivative
2023-02-27 Grant 51,918 $0.00
showing 20 of 186 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 35 3,902,873
2025-12-31 36 4,044,475
2025-09-30 32 3,455,394
2025-06-30 32 3,403,337
2025-03-31 33 4,097,236
2024-12-31 34 4,473,686
2024-09-30 29 2,010,655
2024-06-30 29 2,009,098
2024-03-31 29 1,990,337
2023-12-31 27 1,981,302
2023-09-30 29 1,941,948
2023-06-30 30 1,865,510
Form 13F Holdings
Firm Period DFND Voting Shares
Hilltop National Bank [2026-06-30] SOLE 73 73
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com